- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2023 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Thyroid Disorders
The Endocrinology Network® Thyroid Disorders clinical resource center offers readers insight and perspective into the latest from management of hypothyroidism, hyperthyroidism, thyroid cancers, and other thyroid disorders. One of the most common disorders seen by endocrinologists and those practicing in endocrinology, our thyroid disorders resource center hosts content related to FDA approvals, the latest studies, and guideline updates in management of thyroid disorders.
Study Details Long-Term Quality of Life Improvements After Parathyroidectomy in Primary Hyperparathyroidism
September 15, 2022
A systematic review of studies published from 1998-2021 provides insight into the potential long-term quality of life improvements achieved after undergoing parathyroidectomy in patients who primary hyperparathyroidism, with results shedding light on the quality of life changes up to 10 years after parathyroidectomy.
Preconception Thyroid Function Can Predict Delayed Time to Pregnancy, Risk of Spontaneous Abortion
September 02, 2022
An analysis of more than 11 million women in China details associations between preconception thyroid dysfunction, measured as thyrotropin levels, and delayed time to pregnancy and risk of spontaneous abortion.
Increased Prevalence of Dementia Observed in Older Patients with Hypothyroidism
July 07, 2022
A study of more than 15,000 patients from a national insurance research database suggests older patients with hypothyroidism had an 81% increase in risk of having dementia compared to their counterparts without hypothyroidism.
Parathyroidectomy Can Reduce Adverse Outcomes Risk in Primary Hyperparathyroidism
June 20, 2022
Data from Sweden national registers provide insight into the increased risk of adverse outcomes, including fracture, cardiovascular events, and mortality risk, associated with primary hyperparathyroidism as well as the apparent reductions in risk achieved by undergoing parathyroidectomy.
Finding the "Sweet Spot": Thyroid Hormone Treatment and Cardiovascular Disease
June 01, 2022
Dr. Gregory Weiss examines a recent study that detailed the risk of cardiovascular disease associated with under- and over-treatment with thyroid hormone therapy.
Endocrine Month in Review: May 2022
May 28, 2022
Our endocrine month in review spotlights the most popular articles from the past month. This month's top articles include the approval of tirzepatide, news from AACE & ATTD, and a pair of podcast episodes.
Thyroid Dysfunction Could Increase Risk of Parkinson Disease
May 13, 2022
A systematic review and meta-analysis from AACE 2022 provides an overview of the potential associations between thyroid dysfunction, including both hypothyroidism and hyperthyroidism, and risk of Parkinson disease.
Undertreatment of Hypothyroidism Increases Risk of Adverse Hospital Outcomes
April 27, 2022
A retrospective cohort study provides evidence suggesting higher TSH levels were linked to increased lengths of stay and greater readmission risks among patients with hypothyroidism.
No Radioiodine Proven Noninferior to Postoperative Radioiodine After Thyroidectomy in Low-Risk Thyroid Cancer
March 10, 2022
The ESTIMABL2 trial indicates a follow-up strategy not involving use of radioiodine was noninferior to ablation strategies with radioiodine for the occurrence of functional, structural, and biologic events up to 3 years after thyroidectomy.
Switching Between Levothyroxine Generics Does Not Alter TSH Levels
March 02, 2022
An analysis comparing those who switched against those who did not, results of the study suggest switching levothyroxine generics did not result in a negative impact on TSH levels in adult patients.